In vitro synergy of echinocandins with triazoles against fluconazole-resistant Candida parapsilosis complex isolates.
Candida parapsilosis is a common non-albicans Candida species ranked as the second common cause of bloodstream infections. Azole resistance and elevated echinocandin minimum inhibitory concentrations have been reported for these fungi. This study was conducted to determine the interactions between azoles and echinocandins against C. parapsilosis species complex. Fifteen fluconazole-resistant clinical isolates of C. parapsilosis complex including C. parapsilosis (n = 7), C. orthopsilosis (n = 5), and C. metapsilosis (n = 3) were included. The activity of azoles (fluconazole, itraconazole) and echinocandins (anidulafungin, micafungin) alone and in combination was determined using checkerboard broth microdilution and results were determined based on fractional inhibitory concentration index (FICI). In vitro combination of fluconazole with anidulafungin was found synergistic (FICI: 0.07-0.37) and decreased the minimum inhibitory concentration (MIC) range from 4-64 µg/ml to 0.5-16 µg/ml for fluconazole and from 2-8 µg/ml to 0.125-1 µg/ml for anidulafungin. Similarly, interactions of fluconazole with micafungin (FICI: 0.25-0.5), itraconazole with anidulafungin (FICI: 0.15-0.37) and itraconazole with micafungin (FICI: 0.09-0.37) were synergistic. The combination of fluconazole and itraconazole with either anidulafungin or micafungin demonstrates synergistic interactions against C. parapsilosis species complex, especially against isolates with elevated MIC values. However, the use of these combinations in clinical practice and the clinical relevance of in vitro combination results remains unclear.